viewRedx Pharma Plc

'It's a particularly exciting time for Redx Pharma' - Capital Network's Riccardo Lowi

Capital Network's Healthcare Analyst Riccardo Lowi gives his view on Redx Pharma Plc (LON:REDX).

''The reason it's a particularly exciting time for the company is because they're moving  their two lead candidates into the clinical stage, it's the first time they're moving a drug candidate into human trials'', Lowi says.

Quick facts: Redx Pharma Plc

Price: 7.75 GBX

Market: AIM
Market Cap: £13.83 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Redx Pharma Plc named herein, including the promotion by the Company of Redx Pharma Plc in any Content on the Site, the Company receives from...



Proactive Analyst Ryan Long talks tin mine life

Proactive Analyst Dr. Ryan Long takes a look at the mine life question in the global mining sector and how significant a consideration that is for investors right around the world. Ryan discusses the how the relative significance of long, mid and short mine life projects differ globally and...

5 days ago


Holding(s) in Company

1 day, 5 hours ago

Holding(s) in Company

1 day, 6 hours ago

Form 8.5 (EPT/RI)

2 days, 4 hours ago

Form 8.3 - Redx Pharma plc

2 days, 8 hours ago

Form 8.3 - RedX Pharma PLC

3 days, 3 hours ago

Form 8.5 (EPT/RI)

3 days, 4 hours ago

Result of General Meeting

4 days, 3 hours ago

2 min read